Tuttle Capital Pure Play Photonics ETF (FOTO)
Live price chart, market sentiment, and community perspectives for Tuttle Capital Pure Play Photonics ETF (CBOE: FOTO).
Live price chart, market sentiment, and community perspectives for Tuttle Capital Pure Play Photonics ETF (CBOE: FOTO).
On our desk, we are seeing retail investors sharply split on FOTO. Some view it as a high-beta multi-bagger play given that photonics is replacing copper wiring in AI data centers, while others complain bitterly about the fund hitting successive all-time lows shortly after its May 2026 launch. Sentiment leans cautious due to its steep 0.75% expense ratio compared to broader alternatives.
From a risk management standpoint, FOTO introduces single-variable concentration risks tied heavily to optical transceiver pricing and small/mid-cap optics exposure. While peers like EUV benefit from a broader definition capturing ~45% optics alongside diversified holdings, FOTO's pure-play approach leaves it vulnerable to intense drawdowns, as evidenced by its ~26% all-time decline since inception before recent bounces.
In evaluating the technical architecture of AI workloads, the thesis for funds like FOTO rests entirely on overcoming the copper wall. As AI compute scales exponentially while interconnects lag, data centers are forced to swap electrons for photons using lasers, fibers, and silicon photonics. Analysts must distinguish whether FOTO's holdings like Lumentum and IPG Photonics can outpace supply chain bottlenecks.
As a hedge fund PM tracking the AI optics thematic trade, I noticed FOTO lagging behind competitor ETFs like EUV, which offers better scale, liquidity, and cost efficiency. Although FOTO surged alongside a broader optical communication rally featuring names like Coherent and Ciena, its dilution by non-end AI markets makes it a less attractive vehicle for new institutional positions.
Reviewing recent market action, the optical communication sector experienced a sharp lift, with FOTO jumping over 9% alongside gains in Ciena, Marvell, and Corning. However, quantitative models on our desk flag that the fund's lack of a 1-year historical track record and high turnover make it a tactical trading instrument rather than a stable long-term holding.
Explore plasma cleansing, somatic organ swaps, and BCI.